Latest KFF Health News Stories
‘Free’ Screening? Know Your Rights to Get No-Cost Care
Even a decade in, the Affordable Care Act’s recommendations to simply cover preventive screening and care without cost sharing remain confusing and complex.
Preventive Care May Be Free, but Follow-Up Diagnostic Tests Can Bring Big Bills
Under the Affordable Care Act, insurers cannot charge consumers for various preventive services that have been recommended by experts. But if those screenings indicate more testing is needed to determine whether something is wrong, patients may be on the hook for hundreds or even thousands of dollars for diagnostic services.
Her First Colonoscopy Cost Her $0. Her Second Cost $2,185. Why?
Preventive care, like screening colonoscopies, is supposed to be free of charge to patients under the Affordable Care Act. But some hospitals haven’t gotten the memo.
Betting on ‘Golden Age’ of Colonoscopies, Private Equity Invests in Gastro Docs
An aging population in need of regular cancer screenings has driven private equity companies, seeking profits, to invest in many gastroenterology practices and set up aggressive billing practices. Steep prices on routine tests are one consequence for patients.
KHN’s ‘What the Health?’: More Covid Complications for Congress
Congress is back in session, but covid diagnoses for Vice President Kamala Harris and two Democratic senators have temporarily left the Senate without a working majority to approve continued covid funding. Meanwhile, opponents of the Affordable Care Act have filed yet another lawsuit challenging a portion of the law, and we say goodbye to the late Sen. Orrin Hatch of Utah, who left a long legacy of health laws. Rachel Cohrs of STAT News, Anna Edney of Bloomberg News, and Rebecca Adams of KHN join KHN’s Julie Rovner to discuss these issues and more.
‘Incredibly Concerning’ Lawsuit Threatens No-Charge Preventive Care for Millions
A Texas federal judge, who previously ruled the Affordable Care Act unconstitutional, has signaled his openness to ending the law’s popular coverage requirement for preventive services.
Pruebas para el VPH y el cáncer cervical podrían hacerse en casa
El Instituto Nacional del Cáncer lanzará un estudio que involucrará a unas 5,000 mujeres para evaluar si la autoprueba casera puede equivaler a la que realiza el médico en un consultorio.
NIH Spearheads Study To Test At-Home Screening For HPV And Cervical Cancer
The National Cancer Institute plans to launch a multisite study next year involving roughly 5,000 women to assess whether self-sampling at home for the human papillomavirus that causes cervical cancer is comparable to screening in a doctor’s office.
Monstruoso marketing de millones de dólares impulsa el uso de mamografías 3D
La investigación de KHN muestra que el dinero de la industria ha delineado políticas, a la opinión pública y a la atención al paciente en torno a las pruebas 3D.
A Million-Dollar Marketing Juggernaut Pushes 3D Mammograms
Companies are aggressively touting 3D mammograms, although there’s no evidence they save lives.
Costos adicionales bloquean el tratamiento para prevenir el VIH
Aunque muchas aseguradoras cubren PrEP, los costos por las pruebas adicionales que hay que realizarse pueden bloquear el acceso a esta terapia preventiva.
Even When HIV Prevention Drug Is Covered, Other Costs Block Treatment
The U.S. Preventive Services Task Force recommended that people who are at high risk of contracting HIV take PrEP, a preventive treatment. The decision means most health plans will be required to cover the drugs without charging patients. But the recommendation doesn’t apply to the other clinical and lab services people need.
Podcast: KHN’s ‘What The Health?’ A ‘Healthy’ State Of The Union
Health was a featured player in President Donald Trump’s 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and, for “extra credit,” provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current “Bill of the Month” feature.
Nuevo estudio confirma que la dieta mediterránea sí reduce el riesgo cardíaco
Un estudio que analizó el consumo de esta dieta en 25,000 mujeres, por 12 años, comprobó sus virtudes y cómo actúa el factor preventivo.
Even When Not In Rome, Eat A Mediterranean Diet To Cut Heart Disease Risk
New research not only confirms the heart health benefits of a Mediterranean-style diet, but also tracks these benefits over the long term.
Fish Oil Drug Looks Heart-Healthy. Just Don’t Swallow It Hook, Line And Sinker.
The complete findings of a recent study show the FDA-approved drug Vascepa reduced the likelihood of cardiovascular death, stroke and other heart conditions in some patients. But science didn’t find the same promise for over-the-counter fish oil supplements when tested in healthy people.
Fish Oil And Vitamin D Pills No Guard Against Cancer Or Serious Heart Trouble
And new study finds no reason to get routine vitamin D tests, researchers say.
Píldoras de aceite de pescado y de vitamina D no protegen contra el cáncer o males cardíacos
Los investigadores definieron los males cardíacos graves como el índice combinado de ataques cardíacos, apoplejía y muertes relacionadas con el corazón.
Heart Drug Spotlights Troubling Trends In Drug Marketing
Critics worry the marketing of Vascepa, a purified fish oil product, could prove a fish story.
New Medicare Perk For Diabetes Prevention Stumbles At Rollout
On April 1, Medicare launched a major initiative — a diabetes prevention program for seniors and people with serious disabilities— that is available in only a few cities.
